Literature DB >> 12574274

Rapid detection of Clostridium difficile in feces by real-time PCR.

Simon D Bélanger1, Maurice Boissinot, Natalie Clairoux, François J Picard, Michel G Bergeron.   

Abstract

Clostridium difficile is the major causative agent of nosocomial antibiotic-associated diarrhea, colitis, and pseudomembranous colitis. The pathogenicity of C. difficile is closely related to the production of toxins A and B. Toxigenic C. difficile detection by a tissue culture cytotoxin assay is often considered the "gold standard." However, this assay is time consuming, as it implies an incubation period of at least 24 h. We have developed a rapid real-time fluorescence-based multiplex PCR assay targeting the C. difficile toxin genes tcdA and tcdB, with the Smart Cycler. Two molecular beacons bearing different fluorophores were used as internal probes specific for each amplicon type. The analytical sensitivity of the assay was around 10 genome copies for all nine C. difficile strains tested, representing the 6 most common toxinotypes. The specificity was demonstrated by the absence of amplification with DNA purified from bacterial species other than C. difficile (n = 14), including Clostridium sordellii for which the lethal toxin gene sequence is closely related to the toxin genes of C. difficile. Following a rapid (15 min) and simple fecal sample preparation protocol, both tcdA and tcdB were efficiently amplified from 28 of 29 cytotoxin-positive feces samples. There was no amplification observed with all 27 cytotoxin-negative feces samples tested. This is the first real-time PCR assay for the detection of C. difficile. It is rapid, sensitive, and specific and allows detection of C. difficile directly from feces samples.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12574274      PMCID: PMC149705          DOI: 10.1128/JCM.41.2.730-734.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  36 in total

1.  Development of conventional and real-time PCR assays for the rapid detection of group B streptococci.

Authors:  D Ke; C Ménard; F J Picard; M Boissinot; M Ouellette; P H Roy; M G Bergeron
Journal:  Clin Chem       Date:  2000-03       Impact factor: 8.327

2.  Rapid detection of Shiga toxin-producing bacteria in feces by multiplex PCR with molecular beacons on the smart cycler.

Authors:  Simon D Bélanger; Maurice Boissinot; Christian Ménard; François J Picard; Michel G Bergeron
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

3.  Evaluation of biosite triage Clostridium difficile panel for rapid detection of Clostridium difficile in stool samples.

Authors:  M L Landry; J Topal; D Ferguson; D Giudetti; Y Tang
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

4.  Comparison of toxinotyping and PCR ribotyping of Clostridium difficile strains and description of novel toxinotypes.

Authors:  Maja Rupnik; Jon S Brazier; Brian I Duerden; Miklavz Grabnar; Simon L J Stubbs
Journal:  Microbiology (Reading)       Date:  2001-02       Impact factor: 2.777

5.  Nosocomial acquisition of Clostridium difficile infection.

Authors:  L V McFarland; M E Mulligan; R Y Kwok; W E Stamm
Journal:  N Engl J Med       Date:  1989-01-26       Impact factor: 91.245

6.  Evaluation of methods for detection of toxins in specimens of feces submitted for diagnosis of Clostridium difficile-associated diarrhea.

Authors:  D O'Connor; P Hynes; M Cormican; E Collins; G Corbett-Feeney; M Cassidy
Journal:  J Clin Microbiol       Date:  2001-08       Impact factor: 5.948

Review 7.  How to detect Clostridium difficile variant strains in a routine laboratory.

Authors:  M Rupnik
Journal:  Clin Microbiol Infect       Date:  2001-08       Impact factor: 8.067

Review 8.  Laboratory diagnosis of Clostridium difficile disease.

Authors:  M Delmée
Journal:  Clin Microbiol Infect       Date:  2001-08       Impact factor: 8.067

9.  Fatal pseudomembranous colitis associated with a variant clostridium difficile strain not detected by toxin A immunoassay.

Authors:  S Johnson; S A Kent; K J O'Leary; M M Merrigan; S P Sambol; L R Peterson; D N Gerding
Journal:  Ann Intern Med       Date:  2001-09-18       Impact factor: 25.391

10.  Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea.

Authors:  L Kyne; M Warny; A Qamar; C P Kelly
Journal:  Lancet       Date:  2001-01-20       Impact factor: 79.321

View more
  74 in total

Review 1.  Detection and quantification of gene expression in environmental bacteriology.

Authors:  Freddie H Sharkey; Ibrahim M Banat; Roger Marchant
Journal:  Appl Environ Microbiol       Date:  2004-07       Impact factor: 4.792

Review 2.  Molecular techniques for diagnosis of Clostridium difficile infection: systematic review and meta-analysis.

Authors:  John C O'Horo; Amy Jones; Matthew Sternke; Christopher Harper; Nasia Safdar
Journal:  Mayo Clin Proc       Date:  2012-07       Impact factor: 7.616

3.  Evaluation of a new molecular test, the BD Max Cdiff, for detection of toxigenic Clostridium difficile in fecal samples.

Authors:  Rémi Le Guern; Stéphanie Herwegh; Bruno Grandbastien; René Courcol; Frédéric Wallet
Journal:  J Clin Microbiol       Date:  2012-07-03       Impact factor: 5.948

4.  Comparison of two commercial molecular assays to a laboratory-developed molecular assay for diagnosis of Clostridium difficile infection.

Authors:  Tess Karre; Lynne Sloan; Robin Patel; Jayawant Mandrekar; Jon Rosenblatt
Journal:  J Clin Microbiol       Date:  2010-12-01       Impact factor: 5.948

Review 5.  Clostridium difficile and inflammatory bowel disease: role in pathogenesis and implications in treatment.

Authors:  Orna Nitzan; Mazen Elias; Bibiana Chazan; Raul Raz; Walid Saliba
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

6.  Differential activities of four Lactobacillus casei promoters during bacterial transit through the gastrointestinal tracts of human-microbiota-associated mice.

Authors:  R Oozeer; J P Furet; N Goupil-Feuillerat; J Anba; J Mengaud; G Corthier
Journal:  Appl Environ Microbiol       Date:  2005-03       Impact factor: 4.792

7.  Comparison of a commercial real-time PCR assay for tcdB detection to a cell culture cytotoxicity assay and toxigenic culture for direct detection of toxin-producing Clostridium difficile in clinical samples.

Authors:  Paul D Stamper; Romina Alcabasa; Deborah Aird; Wisal Babiker; Jennifer Wehrlin; Ijeoma Ikpeama; Karen C Carroll
Journal:  J Clin Microbiol       Date:  2008-12-10       Impact factor: 5.948

8.  A novel subtyping assay for detection of Clostridium difficile virulence genes.

Authors:  Stephanie L Angione; Aartik A Sarma; Aleksey Novikov; Leah Seward; Jennifer H Fieber; Leonard A Mermel; Anubhav Tripathi
Journal:  J Mol Diagn       Date:  2014-01-13       Impact factor: 5.568

9.  The correlation between Clostridium-difficile infection and human gut concentrations of Bacteroidetes phylum and clostridial species.

Authors:  E Goldberg; I Amir; M Zafran; U Gophna; Z Samra; S Pitlik; J Bishara
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-09-19       Impact factor: 3.267

10.  Application of isothermal helicase-dependent amplification with a disposable detection device in a simple sensitive stool test for toxigenic Clostridium difficile.

Authors:  Wing Huen A Chow; Cindy McCloskey; Yanhong Tong; Lin Hu; Qimin You; Ciarán P Kelly; Huimin Kong; Yi-Wei Tang; Wen Tang
Journal:  J Mol Diagn       Date:  2008-07-31       Impact factor: 5.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.